These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

695 related articles for article (PubMed ID: 25820555)

  • 1. Metformin reduces ovarian cancer risk in Taiwanese women with type 2 diabetes mellitus.
    Tseng CH
    Diabetes Metab Res Rev; 2015 Sep; 31(6):619-26. PubMed ID: 25820555
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metformin significantly reduces incident prostate cancer risk in Taiwanese men with type 2 diabetes mellitus.
    Tseng CH
    Eur J Cancer; 2014 Nov; 50(16):2831-7. PubMed ID: 25201464
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin may reduce bladder cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    Acta Diabetol; 2014 Apr; 51(2):295-303. PubMed ID: 24509842
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metformin may reduce breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    Breast Cancer Res Treat; 2014 Jun; 145(3):785-90. PubMed ID: 24816805
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metformin and endometrial cancer risk in Chinese women with type 2 diabetes mellitus in Taiwan.
    Tseng CH
    Gynecol Oncol; 2015 Jul; 138(1):147-53. PubMed ID: 25913129
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Use of metformin and risk of kidney cancer in patients with type 2 diabetes.
    Tseng CH
    Eur J Cancer; 2016 Jan; 52():19-25. PubMed ID: 26630530
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metformin use is associated with a reduced risk of acute appendicitis in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Sci Rep; 2021 Jun; 11(1):12400. PubMed ID: 34117321
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metformin and esophageal cancer risk in Taiwanese patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Mar; 8(12):18802-18810. PubMed ID: 27861146
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metformin reduces gastric cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Aging (Albany NY); 2016 Aug; 8(8):1636-49. PubMed ID: 27587088
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rosiglitazone reduces breast cancer risk in Taiwanese female patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jan; 8(2):3042-3048. PubMed ID: 27936468
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metformin use and cervical cancer risk in female patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Sep; 7(37):59548-59555. PubMed ID: 27486978
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pioglitazone does not affect the risk of ovarian cancer: analysis of a nationwide reimbursement database in Taiwan.
    Tseng CH
    Gynecol Oncol; 2013 Oct; 131(1):135-9. PubMed ID: 23877016
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metformin may reduce oral cancer risk in patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2016 Jan; 7(2):2000-8. PubMed ID: 26683519
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metformin and lung cancer risk in patients with type 2 diabetes mellitus.
    Tseng CH
    Oncotarget; 2017 Jun; 8(25):41132-41142. PubMed ID: 28456789
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Metformin and risk of hepatocellular carcinoma in patients with type 2 diabetes.
    Tseng CH
    Liver Int; 2018 Nov; 38(11):2018-2027. PubMed ID: 29956875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prolonged use of human insulin increases breast cancer risk in Taiwanese women with type 2 diabetes.
    Tseng CH
    BMC Cancer; 2015 Nov; 15():846. PubMed ID: 26537234
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin is associated with a lower risk of colorectal cancer in Taiwanese patients with type 2 diabetes: A retrospective cohort analysis.
    Tseng CH
    Diabetes Metab; 2017 Oct; 43(5):438-445. PubMed ID: 28438547
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Metformin reduces thyroid cancer risk in Taiwanese patients with type 2 diabetes.
    Tseng CH
    PLoS One; 2014; 9(10):e109852. PubMed ID: 25303400
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sitagliptin may reduce prostate cancer risk in male patients with type 2 diabetes.
    Tseng CH
    Oncotarget; 2017 Mar; 8(12):19057-19064. PubMed ID: 27661113
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Metformin and risk of developing nasopharyngeal cancer in patients with type 2 diabetes mellitus.
    Tseng CH
    Metabolism; 2018 Aug; 85():223-226. PubMed ID: 29729227
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.